Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System Patrícia SchonhofenIvi Juliana BristotFábio Klamt Current Opinion 14 August 2018 Pages: 697 - 712
Social Skills Deficits in Autism Spectrum Disorder: Potential Biological Origins and Progress in Developing Therapeutic Agents Richard E. Frye Review Article Open access 14 August 2018 Pages: 713 - 734
Refining the Benefit/Risk Profile of Anti-Epileptic Drugs in Headache Disorders Michael J. MarmuraAliza S. Kumpinsky Review Article 02 August 2018 Pages: 735 - 746
Drug Repurposing in Parkinson’s Disease Dilan AthaudaThomas Foltynie Review Article 31 July 2018 Pages: 747 - 761
The Effect of Glatiramer Acetate on Retinal Nerve Fiber Layer Thickness in Patients with Relapsing–Remitting Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study Robert ZivadinovEleonora TavazziBianca Weinstock-Guttman Original Research Article 16 May 2018 Pages: 763 - 770
Use of Emergency Medication in Adult Patients with Epilepsy: A Multicentre Cohort Study from Germany Jeannette KadelSebastian BauerAdam Strzelczyk Original Research Article 17 July 2018 Pages: 771 - 781
Correction to: Treatment Strategies for Dravet Syndrome Kelly G. KnuppElaine C. Wirrell Correction 20 July 2018 Pages: 783 - 783
Cladribine Tablets: A Review in Relapsing MS Emma D. Deeks Adis Drug Evaluation Open access 14 August 2018 Pages: 785 - 796
Amantadine Extended-Release (GOCOVRI™): A Review in Levodopa-Induced Dyskinesia in Parkinson’s Disease Julia PaikSusan J. Keam Adis Drug Evaluation 07 August 2018 Pages: 797 - 806
